<?xml version="1.0" encoding="UTF-8"?>

<CodeSystem xmlns="http://hl7.org/fhir">
  <id value="substance-relationship-type"/>
  <text>
    <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Narrativa gerada: CodeSystem substance-relationship-type</b></p><a name="substance-relationship-type"> </a><a name="hcsubstance-relationship-type"> </a><p>Este  sistema de código  define o seguinte código:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Código</b></td><td><b>Ecrã</b></td><td><b>Definição</b></td></tr><tr><td style="white-space:nowrap">salt-parent<a name="substance-relationship-type-salt-parent"> </a></td><td>Sal-Base</td><td>Relação entre sal e base livre</td></tr><tr><td style="white-space:nowrap">parent-salt<a name="substance-relationship-type-parent-salt"> </a></td><td>Base-Sal</td><td>Relação entre base livre e sal</td></tr><tr><td style="white-space:nowrap">active-moiety<a name="substance-relationship-type-active-moiety"> </a></td><td>Moiety Ativa</td><td>Parte farmacologicamente ativa da molécula</td></tr><tr><td style="white-space:nowrap">prodrug-drug<a name="substance-relationship-type-prodrug-drug"> </a></td><td>Pró-fármaco-Fármaco</td><td>Relação pró-fármaco e fármaco ativo</td></tr><tr><td style="white-space:nowrap">metabolite<a name="substance-relationship-type-metabolite"> </a></td><td>Metabólito</td><td>Produto de metabolismo</td></tr><tr><td style="white-space:nowrap">isomer<a name="substance-relationship-type-isomer"> </a></td><td>Isômero</td><td>Isômero estrutural ou estereoisômero</td></tr><tr><td style="white-space:nowrap">enantiomer<a name="substance-relationship-type-enantiomer"> </a></td><td>Enantiômero</td><td>Par enantiomérico</td></tr><tr><td style="white-space:nowrap">polymorph<a name="substance-relationship-type-polymorph"> </a></td><td>Polimorfo</td><td>Forma polimórfica</td></tr><tr><td style="white-space:nowrap">solvate-parent<a name="substance-relationship-type-solvate-parent"> </a></td><td>Solvato-Base</td><td>Solvato/hidrato e forma anidra</td></tr><tr><td style="white-space:nowrap">impurity<a name="substance-relationship-type-impurity"> </a></td><td>Impureza</td><td>Impureza relacionada</td></tr></table></div>
  </text>
  <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm">
    <valueInteger value="0">
      <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom">
        <valueCanonical value="https://idmp-br.github.io/brig-idmp-brasil/ImplementationGuide/brig.idmp.brazil"/>
      </extension>
    </valueInteger>
  </extension>
  <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status">
    <valueCode value="draft">
      <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom">
        <valueCanonical value="https://idmp-br.github.io/brig-idmp-brasil/ImplementationGuide/brig.idmp.brazil"/>
      </extension>
    </valueCode>
  </extension>
  <url value="https://idmp-br.github.io/brig-idmp-brasil/CodeSystem/substance-relationship-type"/>
  <version value="0.0.3"/>
  <name value="SubstanceRelationshipType"/>
  <title value="Tipo de Relacionamento entre Substâncias"/>
  <status value="active"/>
  <date value="2025-10-30"/>
  <publisher value="IDMP Brasil"/>
  <contact>
    <name value="IDMP Brasil"/>
    <telecom>
      <system value="url"/>
      <value value="https://idmp-br.github.io"/>
    </telecom>
    <telecom>
      <system value="email"/>
      <value value="eugenio@farmaco.io"/>
    </telecom>
  </contact>
  <contact>
    <name value="IDMP Brasil"/>
    <telecom>
      <system value="email"/>
      <value value="eugenio@farmaco.io"/>
    </telecom>
    <telecom>
      <system value="url"/>
      <value value="https://idmp-br.github.io/brig-idmp-brasil"/>
    </telecom>
  </contact>
  <description value="Tipos de relacionamentos entre substâncias químicas"/>
  <jurisdiction>
    <coding>
      <system value="urn:iso:std:iso:3166"/>
      <code value="BR"/>
    </coding>
  </jurisdiction>
  <copyright value="Copyright © 2025 Farmaco.io. Este trabalho está licenciado sob a MIT License. FHIR® é marca registrada da HL7 International, usada com permissão."/>
  <caseSensitive value="true"/>
  <content value="complete"/>
  <count value="10"/>
  <concept>
    <code value="salt-parent"/>
    <display value="Sal-Base"/>
    <definition value="Relação entre sal e base livre"/>
  </concept>
  <concept>
    <code value="parent-salt"/>
    <display value="Base-Sal"/>
    <definition value="Relação entre base livre e sal"/>
  </concept>
  <concept>
    <code value="active-moiety"/>
    <display value="Moiety Ativa"/>
    <definition value="Parte farmacologicamente ativa da molécula"/>
  </concept>
  <concept>
    <code value="prodrug-drug"/>
    <display value="Pró-fármaco-Fármaco"/>
    <definition value="Relação pró-fármaco e fármaco ativo"/>
  </concept>
  <concept>
    <code value="metabolite"/>
    <display value="Metabólito"/>
    <definition value="Produto de metabolismo"/>
  </concept>
  <concept>
    <code value="isomer"/>
    <display value="Isômero"/>
    <definition value="Isômero estrutural ou estereoisômero"/>
  </concept>
  <concept>
    <code value="enantiomer"/>
    <display value="Enantiômero"/>
    <definition value="Par enantiomérico"/>
  </concept>
  <concept>
    <code value="polymorph"/>
    <display value="Polimorfo"/>
    <definition value="Forma polimórfica"/>
  </concept>
  <concept>
    <code value="solvate-parent"/>
    <display value="Solvato-Base"/>
    <definition value="Solvato/hidrato e forma anidra"/>
  </concept>
  <concept>
    <code value="impurity"/>
    <display value="Impureza"/>
    <definition value="Impureza relacionada"/>
  </concept>
</CodeSystem>